Yahoo finance API is not available right now, please try again soon...

Cramer’s week ahead: A short week on Wall Street stuffed with earnings reports

Cramer's week ahead: A short week on Wall Street stuffed with earnings reports

Cramer’s week ahead: A short week on Wall Street stuffed with earnings reports

The stock market will be closed on Thanksgiving Day Thursday and will close at 1 p.m. on Friday. There will, however, be a full slate of earnings reports coming out in the days prior. Cramer gave … Continue reading at

Target praises ‘well-organized’ back rooms in earnings call after reports of overcrowded conditions

“Our teams are telling us that their back rooms have never been so well-organized going into a holiday season,” Target COO John Mulligan said. Continue reading at

The worst-performing S&P 500 stock is about to report earnings

Macy’s may not be the best stocking stuffer this holiday season. The retailer, which is down nearly 80% from its 2015 peak, is set to report earnings Thursday morning. founder Todd … Continue reading at

Long Term Investments

How Lowe’s Earnings Report Shows That its Catching Up to Home Depot

Lowe’s (LOW – Get Report) said earnings for the three months ending on November 1 came in at $ 1.41 per share, up 35.6% from the same period last year and firmly ahead of the Street consensus forecast … Continue reading at

Silgan (SLGN) Up 1.2% Since Last Earnings Report: Can It Continue?

It has been about a month since the last earnings report for Silgan Holdings (SLGN). Shares have added about 1.2% in that time frame, underperforming the S&P 500. Will the recent positive trend … Continue reading at

Capital: The Story of Long-Term Investment Excellence
Go inside the elite investment firm with Capital. The Capital Group is one of the world?s largest investment management organizati…

The Permanent Portfolio: Harry Browne’s Long-Term Investment Strategy
An up close look at an investment strategy that can handle today’s uncertain financial environment Market uncertainty cannot be el…

Common Stocks as Long Term Investments
2012 Reprint of 1928 Edition. Exact facsimile of the original edition, not reproduced with Optical Recognition Software. Edgar Law…

Long Term Investments

Earnings Season Report: Recap of Q3 2019

Arm yourself with this information emailed to you every trading day. Sign up and get the Earnings Season Report, Earnings Report, Earnings Results Report and Unusual Activity report everyday in your … Continue reading at

Alexion (ALXN) Up 3.3% Since Last Earnings Report: Can It Continue?

A month has gone by since the last earnings report for Alexion Pharmaceuticals (ALXN). Shares have added about 3.3% in that time frame, outperforming the S&P 500. Will the recent positive trend … Continue reading at

Home Depot’s Critical Support in Play After Earnings Fall

Shares of Home Depot (HD – Get Report) were taking a tumble on Tuesday, down more than 5% after Wall Street reacts to the company’s third-quarter earnings report. Given the headline results, investors … Continue reading at

Target Reports 4.5% Comp Sales Growth, Remains a Strong Pick

Target (NYSE: TGT) reported very strong third-quarter earnings results that underscore its ability to operate within a shifting retail environment. With solid same-store sales, robust online growth, … Continue reading at

Lowe's Earnings: LOW Stock Surges 4% on Q3 Results, Outlook

Now for a more in-depth look at the current Lowe's earnings report. Adjusted earnings per share are up 35.58% from $ 1.04 in the third quarter of 2018. Revenue is down slightly from the $ 17.42 billion … Continue reading at

* We all know Gilead Sciences is a favorite of The Motley Fool, and it’s no surprise why. With companies like AbbVie struggling to maintain position in the market after reports to the FDA about liver failure and complications, the other mid-grade companies are vying for that spot.

As time goes on, will these companies put themselves out of business by curing all these hepatitis C patients, or will the future expansion into emerging markets like Japan and Europe help to curb that possibility, allowing for more innovative cures to be generated, in turn expanding profits and market domination?

This podcast was recorded on 11/4/2015.

Imagine owning (up over an insane 4,000% since 2001) when Internet sales rendered big-box retailers obsolete… Now an industry 99% of us use daily is set to implode… And 3 established companies are positioned to take advantage. Click for a stunning presentation.

Subscribe to The Motley Fool’s YouTube Channel:
Or, follow our Google+ page:

Inside The Motley Fool: Check out our Culture Blog!
Join our Facebook community:
Follow The Motley Fool on Twitter:

Long Term Investments

Tags: , , , , , , , ,
Previous Post

Cramer’s week ahead: A short week on Wall Street stuffed with earnings reports

Next Post

Best And Worst Q4 2019: Utilities ETFs And Mutual Funds


    • Professional Welders
    • November 23, 2019

    Great Review, 99% of people in developing countries cant afford $1000 per pill even in developed countries its tough. Not sure if they shall drop the price when the R&D is paid for and then go for more volume….Not sure I will invest I do need some medical stocks though

    View Comment
%d bloggers like this: